Introduction Venous and arterial thromboses are frequently observed complications in
patients with severe novel coronavirus disease 2019 (COVID-19) infection who require …

Introduction There are no clear data about the incidence and the prophylactic strategies of
arterial and venous thromboembolic events (TE) in COVID-19 ambulatory patients. Thus, we …

It is well established that the risk of venous thromboembolism is high in coronavirus disease
19 (COVID-19). The frequency of arterial thromboembolic events (ATEs) in hospitalized …

Background Several observational studies have reported the rate of venous and arterial
thrombotic events in patients infected with COVID-19, with conflicting results. The aim of this …

Introduction Venous thromboembolism (VTE) has been observed as a frequent complication
in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring …

Background High incidence of venous thromboembolic complications in coronavirus
disease 2019 (COVID-19) patients was noted recently. Objective This study aimed to …

Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …

This study aims to review the available literature pertinent to vascular complications in
COVID-19. A systematic search was performed using PubMed and Google Scholar to …

Background: Emerging evidence shows that coronavirus disease 2019 (COVID-19) is
commonly complicated by coagulopathy, and venous thromboembolism (VTE) is considered …

Data regarding the occurrence of venous thromboembolic events (VTE), including acute
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …